Innoviva Inc (INVA)
14.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 17, 16:00
14.47
0.00 (0.00%)
After-Hours: 20:00
Innoviva Gross Profit Margin (Quarterly): 84.70% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 84.70% |
| September 30, 2023 | 84.86% |
| June 30, 2023 | 88.91% |
| Date | Value |
|---|---|
| March 31, 2023 | 86.45% |
| December 31, 2022 | 84.63% |
| September 30, 2022 | 94.53% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
84.63%
Minimum
Dec 2022
94.53%
Maximum
Sep 2022
87.35%
Average
85.66%
Median
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.11% |
| Return on Assets | 15.20% |
| Return on Invested Capital | 16.93% |
| Profit Margin (Quarterly) | 71.68% |
| Operating Margin (Quarterly) | 43.72% |
| Return on Net Operating Assets | 45.15% |